Valeant says CEO J. Michael Pearson hospitalized with severe pneumonia
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Valeant Pharma (VRX) Tests $100 Level as Traders Await Pearson Update
December 29, 2015 11:10 AM ESTValeant Pharma (NYSE: VRX) has taken out yesterday's lows and is testing the $100 level with radio silence from the company about the condition of CEO Mike Pearson. Shares last traded at $100.06, down 2%.
Over the weekend, Pearson was hospitalized for severe pneumonia. Yesterday,... More
Valeant's (VRX) Walgreens (WBA) Deal Execution Seen as Area of Concern with Pearson on Leave - DJ
December 28, 2015 3:14 PM ESTIn the absence of CEO Mike Pearson, a key concern for Valeant Pharma (NYSE: VRX) will be executing the new drug distribution deal with Walgreens Boots Alliance (NASDAQ: WBA), Dow Jones reported.
Pearson handled much of the... More
Pershing Square Won't Comment on Valeant Pharma (VRX) CEO Medical Leave News
December 28, 2015 12:24 PM ESTPershing Square offered no comment to StreetInsider on news Valeant Pharma (NYSE: VRX) J. Michael Pearson will be on a medical leave of absence after being hospitalized with a severe case of pneumonia.
"PSCM is not commenting," a spokesperson said.
The... More
Valeant Pharma (VRX) CEO Hospitalized with Severe Pneumonia
December 28, 2015 6:13 AM ESTValeant Pharma (NYSE: VRX) CEO, Mike Pearson, has been hospitalized with severe pneumonia. The company does not expect his absence to disrupt operations since Mr. Pearson had scheduled an absence during the holiday period.
Commenting on the news, Mizho analyst Irina Koffler said, "We... More
